These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30442375)

  • 21. Association between the quality of life and asymptomatic episodes of paroxysmal atrial fibrillation in the J-RHYTHM II study.
    Yamamoto M; Watanabe E; Suzuki T; Yamazaki T; Ohtsu H; Ozaki Y; Ogawa S; Yamashita T;
    J Cardiol; 2014 Jul; 64(1):64-9. PubMed ID: 24373865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Freeman JV; Simon DN; Go AS; Spertus J; Fonarow GC; Gersh BJ; Hylek EM; Kowey PR; Mahaffey KW; Thomas LE; Chang P; Peterson ED; Piccini JP;
    Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):393-402. PubMed ID: 26058720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular hypertrophy determines the severity of diastolic dysfunction in patients with nonvalvular atrial fibrillation and preserved left ventricular systolic function.
    Moon J; Rim SJ; Cho IJ; Lee SH; Choi S; Chung WJ; Byun YS; Ryu SK; Pyun WB; Kim JY
    Clin Exp Hypertens; 2010; 32(8):540-6. PubMed ID: 21091364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of atrial fibrillation ablation on left ventricular filling pressure and left atrial remodeling.
    Santos SN; Henz BD; Zanatta AR; Barreto JR; Loureiro KB; Novakoski C; Santos MV; Giuseppin FF; Oliveira EM; Leite LR
    Arq Bras Cardiol; 2014 Dec; 103(6):485-92. PubMed ID: 25590928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular fibrosis in atrial fibrillation.
    Shantsila E; Shantsila A; Blann AD; Lip GY
    Am J Cardiol; 2013 Apr; 111(7):996-1001. PubMed ID: 23332595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'It's like a frog leaping about in your chest': Illness and treatment perceptions in persistent atrial fibrillation.
    Taylor EC; O'Neill M; Hughes LD; Carroll S; Moss-Morris R
    Br J Health Psychol; 2018 Feb; 23(1):3-21. PubMed ID: 28875586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The presence of contractile reserve has no predictive value for the evolution of left ventricular function following atrio-ventricular node ablation in patients with permanent atrial fibrillation.
    Szili-Torok T; Bountioukos M; Muskens AJ; Theuns DA; Poldermans D; Roelandt JR; Jordaens LJ
    Eur J Echocardiogr; 2005 Oct; 6(5):344-50. PubMed ID: 15975852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Health-related quality of life of patients with atrial fibrillation managed by cardiologists: MOVE study].
    Kirch W; Pittrow D; Bosch RF; Kohlhaussen A; Willich SN; Rosin L; Bonnemeier H;
    Dtsch Med Wochenschr; 2010 Mar; 135 Suppl 2():S26-32. PubMed ID: 20221975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated left ventricular filling pressure estimated by E/E' ratio after exercise predicts development of new-onset atrial fibrillation independently of left atrial enlargement among elderly patients without obvious myocardial ischemia.
    Takagi T; Takagi A; Yoshikawa J
    J Cardiol; 2014 Feb; 63(2):128-33. PubMed ID: 24012433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF).
    Ha AC; Breithardt G; Camm AJ; Crijns HJ; Fitzmaurice GM; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Dorian P
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):896-904. PubMed ID: 25387780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left atrial strain - an early marker of left ventricular diastolic dysfunction in patients with hypertension and paroxysmal atrial fibrillation.
    Jarasunas J; Aidietis A; Aidietiene S
    Cardiovasc Ultrasound; 2018 Oct; 16(1):29. PubMed ID: 30382851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of quality of life, anxiety, and depression with left atrial ablation outcomes.
    Efremidis M; Letsas KP; Lioni L; Giannopoulos G; Korantzopoulos P; Vlachos K; Dimopoulos NP; Karlis D; Bouras G; Sideris A; Deftereos S
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):703-11. PubMed ID: 24809737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of the assessment of the systolic and diastolic myocardial function of the left atrium in patients with paroxysmal atrial fibrillation and low CHADS(2) index treated with catheter ablation therapy.
    Morris DA; Parwani A; Huemer M; Wutzler A; Bekfani T; Attanasio P; Friedrich K; Kühnle Y; Haverkamp W; Boldt LH
    Am J Cardiol; 2013 Apr; 111(7):1002-11. PubMed ID: 23337834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale.
    Dorian P; Guerra PG; Kerr CR; O'Donnell SS; Crystal E; Gillis AM; Mitchell LB; Roy D; Skanes AC; Rose MS; Wyse DG
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):218-24. PubMed ID: 19808471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychopathology and symptoms of atrial fibrillation: implications for therapy.
    Gehi AK; Sears S; Goli N; Walker TJ; Chung E; Schwartz J; Wood KA; Guise K; Mounsey JP
    J Cardiovasc Electrophysiol; 2012 May; 23(5):473-8. PubMed ID: 22429764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation.
    Dorian P; Paquette M; Newman D; Green M; Connolly SJ; Talajic M; Roy D
    Am Heart J; 2002 Jun; 143(6):984-90. PubMed ID: 12075253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry.
    Steg PG; Alam S; Chiang CE; Gamra H; Goethals M; Inoue H; Krapf L; Lewalter T; Merioua I; Murin J; Naditch-Brûlé L; Ponikowski P; Rosenqvist M; Silva-Cardoso J; Zharinov O; Brette S; Neill JO;
    Heart; 2012 Feb; 98(3):195-201. PubMed ID: 21948959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between left atrial phasic conduit function and early atrial fibrillation recurrence in patients undergoing electrical cardioversion.
    Degiovanni A; Boggio E; Prenna E; Sartori C; De Vecchi F; Marino PN;
    Clin Res Cardiol; 2018 Apr; 107(4):329-337. PubMed ID: 29181725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of factors affecting plasma BNP levels in patients with chronic atrial fibrillation and preserved left ventricular systolic function.
    Kim BJ; Hwang SJ; Sung KC; Kim BS; Kang JH; Lee MH; Park JR
    Int J Cardiol; 2007 May; 118(2):145-50. PubMed ID: 16959341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.